Kenneth M.

Kenneth M. is a seasoned professional in the field of quality assurance and quality control within the biopharmaceutical industry, currently serving as the Senior Director QA and Team Leader at Samsung Biologics since December 2023. Kenneth's extensive experience includes directing various QA teams, oversight of quality systems for tech transfer and process validation, and managing analytical quality functions across multiple organizations. Previous roles include Director of Quality at 3P Biopharmaceuticals and Director CMC Quality Assurance at Samsung Biologics, where responsibilities encompassed leading teams, interfacing with clients, and authoring crucial technical and quality documents. Kenneth's background also features significant contributions as a QC Manager at Bristol-Myers Squibb and as an NPI Scientist at Genzyme, complemented by a Post-Doctoral Fellowship at the University of Alberta and a PhD in Molecular Biology from Dublin City University.